KLK3 and posterior cortical atrophy: In patients treated with primary therapy (surgery or radiotherapy) for localized prostate cancer (PCa), biochemical relapses (BR) with the rise in the isolated prostate-specific antigen (PSA) are observed in up to 30% of them within 7 years following the primary therapy [1].